{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T05:46:27Z","timestamp":1782279987886,"version":"3.54.5"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Communication impairments are common, multifaceted, and progressive symptoms of Parkinson\u2019s disease (PD), and have deleterious impacts on individual wellbeing. Self-awareness of communication impairments and the rate and extent of decline in speech skills vary substantially across individuals and are challenging to predict. To address these, we aimed to (1) evaluate associations between non-motor symptoms (NMS) and speech impairment at year seven and (2) compare the progression of self-perceived and examiner-rated speech impairment ratings scores across a seven-year follow-up period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>The study included 417 PD participants from the Parkinson\u2019s Progression Marker Initiative. NMS were assessed using validated instruments covering sleep, olfaction, neurobehavioral, autonomic, and neuropsychological domains. Speech severity was measured using the Movement Disorder Society\u2013Unified Parkinson\u2019s Disease Rating Scale. Multivariate ordinal logistic regression examined associations between baseline NMS and speech severity at year seven. Changes in speech severity scores over seven years were analyzed using Friedman\u2019s test.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Several NMS were associated with self-perceived and examiner-rated speech severity at year seven. Baseline REM sleep behavior disorder and autonomic dysfunction were associated with significantly higher odds of speech impairment at year seven. For self-perceived speech, odds ratios (OR) and 95% confidence interval (CI) were 1.58 (1.18\u20132.12) for REM sleep behavior disorder and 1.71 (1.24\u20132.36) for autonomic dysfunction. For examiner-rated speech, ORs were 1.45 (1.06\u20131.98) and 1.71 (1.21\u20132.42), respectively. Daytime sleepiness was associated with worse examiner-rated speech scores at year seven (OR\u202f=\u202f1.51, 95% CI 1.10\u20132.09). Both self-perceived and examiner-rated speech impairments worsened over seven years (\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.001), with no significant differences between the two assessments (\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;gt;\u202f0.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Several NMS were associated with worse speech ratings at year seven. These simple and readily accessible instruments may help identify individuals at greater risk of worsening speech skills, with the goal of enabling timely and targeted speech and language therapy. The consistency between self-perceived and examiner-rated speech scores suggests individuals with PD maintain good insight into their speech impairments, despite a decline in communication abilities.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fneur.2026.1827374","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T04:48:59Z","timestamp":1782276539000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Associations of non-motor symptoms with perceptual speech impairments in Parkinson\u2019s disease"],"prefix":"10.3389","volume":"17","author":[{"given":"Rui","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Health Sciences, Sacred Heart University","place":["Fairfield, CT, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciara","family":"Leydon","sequence":"additional","affiliation":[{"name":"Department of Communication Disorders, Sacred Heart University","place":["Fairfield, CT, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,24]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1002\/mds.24985","article-title":"Defining at-risk populations for Parkinson\u2019s disease: lessons from ongoing studies","volume":"27","author":"Berg","year":"2012","journal-title":"Mov Disord"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"101818","DOI":"10.1016\/j.bspc.2019.101818","article-title":"Glottal source analysis of voice deficits in newly diagnosed drug-na\u00efve patients with Parkinson\u2019s disease: correlation between acoustic speech characteristics and non-speech motor performance","volume":"57","author":"Novotn\u00fd","year":"2020","journal-title":"Biomed Signal Process Control"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.parkreldis.2019.04.026","article-title":"Speech difficulties in early de novo patients with Parkinson\u2019s disease","volume":"64","author":"Polychronis","year":"2019","journal-title":"Parkinsonism Relat Disord"},{"key":"ref4","volume-title":"Motor Speech Disorders: Substrates, Differential Diagnosis, and Management","author":"Duffy","year":"2013"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1155\/1999\/327643","article-title":"Speech impairment in a large sample of patients with Parkinson\u2019s disease","volume":"11","author":"Ho","year":"1999","journal-title":"Behav Neurol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"e2124","DOI":"10.1212\/WNL.0000000000012878","article-title":"Defining speech subtypes in De novo Parkinson disease: response to long-term levodopa therapy","volume":"97","author":"Rusz","year":"2021","journal-title":"Neurology"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/S1474-4422(17)30328-9","article-title":"Large-scale identification of clinical and genetic predictors of motor progression in patients with newly diagnosed Parkinson\u2019s disease: a longitudinal cohort study and validation","volume":"16","author":"Latourelle","year":"2017","journal-title":"Lancet Neurol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1044\/2023_AJSLP-22-00350","article-title":"Sex differences in the speech of persons with and without Parkinson\u2019s disease","volume":"33","author":"Houle","year":"2024","journal-title":"Am J Speech Lang Pathol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1044\/2021_JSLHR-21-00216","article-title":"Progression of self-perceived speech and swallowing impairment in early stage Parkinson\u2019s disease: longitudinal analysis of the unified Parkinson\u2019s disease rating scale","volume":"65","author":"Watts","year":"2022","journal-title":"J Speech Lang Hear Res"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1002\/mds.26431","article-title":"MDS research criteria for prodromal Parkinson\u2019s disease","volume":"30","author":"Berg","year":"2015","journal-title":"Mov Disord"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1093\/ageing\/aft085","article-title":"Mild cognitive impairment in Parkinson\u2019s disease","volume":"42","author":"Yarnall","year":"2013","journal-title":"Age Ageing"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1002\/mds.20324","article-title":"Sydney Multicenter study of Parkinson\u2019s disease: non-L-dopa-responsive problems dominate at 15 years","volume":"20","author":"Hely","year":"2005","journal-title":"Mov Disord"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1109\/T-AFFC.2012.38","article-title":"Detecting depression severity from vocal prosody","volume":"4","author":"Yang","year":"2013","journal-title":"IEEE Trans Affect Comput"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.bandl.2018.08.002","article-title":"Communication impairment in Parkinson\u2019s disease: impact of motor and cognitive symptoms on speech and language","volume":"185","author":"Smith","year":"2018","journal-title":"Brain Lang"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"389195","DOI":"10.1155\/2013\/389195","article-title":"Progression of voice and speech impairment in the course of Parkinson\u2019s disease: a longitudinal study","volume":"2013","author":"Skodda","year":"2013","journal-title":"Parkinsons Dis"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1044\/2022_JSLHR-21-00485","article-title":"Longitudinal effects of Parkinson\u2019s disease on speech breathing during an extemporaneous connected speech task","volume":"65","author":"Darling-White","year":"2022","journal-title":"J Speech Lang Hear Res"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.jvoice.2017.08.018","article-title":"Differences between subjective and objective assessment of speech deficiency in Parkinson disease","volume":"32","author":"Pawlukowska","year":"2018","journal-title":"J Voice"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.pneurobio.2011.09.005","article-title":"The Parkinson progression marker initiative (PPMI)","volume":"95","author":"Marek","year":"2011","journal-title":"Prog Neurobiol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1001\/jamaneurol.2013.3861","article-title":"Association of cerebrospinal fluid \u03b2-amyloid 1-42, T-tau, P-tau181, and \u03b1-synuclein levels with clinical features of drug-naive patients with early Parkinson disease","volume":"70","author":"Kang","year":"2013","journal-title":"JAMA Neurol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1136\/jnnp.2006.103788","article-title":"Gender differences in Parkinson\u2019s disease","volume":"78","author":"Haaxma","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"100074","DOI":"10.1016\/j.prdoa.2020.100074","article-title":"Self-perceptions of speech, voice, and swallowing in motor phenotypes of Parkinson\u2019s disease","volume":"3","author":"Dumican","year":"2020","journal-title":"Clin Park Relat Disord"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1007\/s00702-020-02229-4","article-title":"Speech disorder and vocal tremor in postural instability\/gait difficulty and tremor dominant subtypes of Parkinson\u2019s disease","volume":"127","author":"Tykalov\u00e1","year":"2020","journal-title":"J Neural Transm"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S1474-4422(06)70373-8","article-title":"Non-motor symptoms of Parkinson\u2019s disease: diagnosis and management","volume":"5","author":"Chaudhuri","year":"2006","journal-title":"Lancet Neurol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.parkreldis.2020.02.001","article-title":"Non-motor symptoms and striatal dopamine transporter binding in early Parkinson\u2019s disease","volume":"72","author":"Liu","year":"2020","journal-title":"Parkinsonism Relat Disord"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/s41531-022-00373-0","article-title":"Dysautonomia and REM sleep behavior disorder contributions to progression of Parkinson's disease phenotypes","volume":"8","author":"Riboldi","year":"2022","journal-title":"NPJ Parkinson's disease"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"823","DOI":"10.3233\/JPD-230459","article-title":"Symmetric and profound monoaminergic degeneration in Parkinson's disease with premotor REM sleep behavior disorder","volume":"14","author":"Woo","year":"2024","journal-title":"J Parkinsons Dis"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1383714","DOI":"10.3389\/fnhum.2024.1383714","article-title":"A neurocomputational view of the effects of Parkinson's disease on speech production","volume":"18","author":"Manes","year":"2024","journal-title":"Front Hum Neurosci"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"106944","DOI":"10.1016\/j.parkreldis.2024.106944","article-title":"Voice self-assessment in individuals with Parkinson\u2019s disease as compared to general voice disorders","volume":"123","author":"Contreras-Ruston","year":"2024","journal-title":"Parkinsonism Relat Disord"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1044\/2016_JSLHR-S-15-0197","article-title":"The relationship between speech production and speech perception deficits in Parkinson\u2019s disease","volume":"59","author":"De Keyser","year":"2016","journal-title":"J Speech Lang Hear Res"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.parkreldis.2016.05.018","article-title":"Speech prosody impairment predicts cognitive decline in Parkinson\u2019s disease","volume":"29","author":"Rektorova","year":"2016","journal-title":"Parkinsonism Relat Disord"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1044\/1058-0360(2010\/09-0105)","article-title":"Establishing validity of the consensus auditory-perceptual evaluation of voice (CAPE-V)","volume":"20","author":"Zraick","year":"2011","journal-title":"Am J Speech Lang Pathol"},{"key":"ref32","first-page":"227","article-title":"Reliability of speech intelligibility ratings using the unified Parkinson disease rating scale","volume":"11","author":"Zraick","year":"2003","journal-title":"J Med Speech Lang Pathol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1136\/practneurol-2017-0016.","article-title":"Communication changes in Parkinson\u2019s disease","volume":"17","author":"Miller","year":"2017","journal-title":"Pract Neurol"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1827374\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T04:49:04Z","timestamp":1782276544000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1827374\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,24]]},"references-count":33,"alternative-id":["10.3389\/fneur.2026.1827374"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2026.1827374","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,24]]},"article-number":"1827374"}}